Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study.
Frasci G, Panza N, Comella P, Cartení G, Guida T, Nicolella GP, Natale M, Lombardi R, Apicella A, Pacilio C, Gravina A, Lapenta L, Comella G. Frasci G, et al. Among authors: comella p, comella g. Ann Oncol. 1999 Mar;10(3):355-8. doi: 10.1023/a:1008301222560. Ann Oncol. 1999. PMID: 10355583 Free article. Clinical Trial.
Weekly dose-dense cisplatin-epirubicin-paclitaxel administration with granulocyte colony-stimulating factor support does not substantially improve prognosis in extensive disease small-cell lung cancer. A SICOG phase II study.
Frasci G, Comella P, Carreca I, DeCataldis G, Muci D, Brunetti C, Russo A, Palmeri S, D'Aniello R, Giordano R, D'Aiuto M, Comella G; Southern Italy Cooperative Oncology Group. Frasci G, et al. Among authors: comella p, comella g. Oncology. 2005;68(2-3):223-9. doi: 10.1159/000086778. Epub 2005 Jul 7. Oncology. 2005. PMID: 16015038 Clinical Trial.
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patients.
Frasci G, D'Aiuto G, Thomas R, Comella P, Di Bonito M, Lapenta L, D'Aiuto M, Botti G, Vallone P, De Rosa V, D'Aniello R, Giordano R, Comella G. Frasci G, et al. Among authors: comella p, comella g. Oncology. 2005;68(4-6):391-7. doi: 10.1159/000086980. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020968 Clinical Trial.
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Comella P, Frasci G, Panza N, De Cataldis G, Cioffi R, Curcio C, Nicolella D, Micillo E, Ianniello GP, Biondi E, Perchard J, Comella G. Comella P, et al. Among authors: comella g. Lung Cancer. 1996 Aug;15(1):103-14. doi: 10.1016/0169-5002(96)00575-2. Lung Cancer. 1996. PMID: 8865128 Clinical Trial.
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G. Comella P, et al. Among authors: comella g. Br J Cancer. 1996 Dec;74(11):1805-11. doi: 10.1038/bjc.1996.634. Br J Cancer. 1996. PMID: 8956797 Free PMC article. Clinical Trial.
140 results